A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus poses serious threats to the global public health and leads to worldwide crisis. No effective drug or vaccine is readily available. The viral RNA-dependent RNA polymerase (RdRp) is a promising therapeutic target. A hybr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haiping, Yang, Yang, Li, Junxin, Wang, Min, Saravanan, Konda Mani, Wei, Jinli, Tze-Yang Ng, Justin, Tofazzal Hossain, Md., Liu, Maoxuan, Zhang, Huiling, Ren, Xiaohu, Pan, Yi, Peng, Yin, Shi, Yi, Wan, Xiaochun, Liu, Yingxia, Wei, Yanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774833/
https://www.ncbi.nlm.nih.gov/pubmed/33382685
http://dx.doi.org/10.1371/journal.pcbi.1008489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774833/
https://www.ncbi.nlm.nih.gov/pubmed/33382685
http://dx.doi.org/10.1371/journal.pcbi.1008489

Ejemplares similares